Synthesis and characterization of Fe-based metal and oxide based nanoparticles: Discoveries and research highlights of potential applications in biology and medicine

Recent Patents on Nanotechnology

Volumn 8, Issue 1, 2014, Pages 52-61

  Long, Nguyen Viet ^a,b,c,d,e   Thi, Cao Minh ^f   Yong, Yang ^a   Cao, Yanqin ^a   Wu, Haibo ^a   Nogami, Masayuki ^a,e  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b KYUSHU UNIVERSITY   (Japan)

^c POSTS AND TELECOMMUNICATIONS INSTITUTE OF TECHNOLOGY   (Viet Nam)

^d VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

^e NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^f HO CHI MINH CITY UNIVERSITY OF TECHNOLOGY   (Viet Nam)

Author keywords

Biology and medicine; Biomedical applications; Fe based bimetallic nanoparticles; Fe based core shell nanoparticles; Fe based mixture nanoparticles; Fe based nanoparticles; Fe based nanostructures; Hyperthermia; Iron metal; Magnetic nanoparticles; Magnetic properties; Magnetic resonance imaging (MRI); Nano fluids

Indexed keywords

BIOLOGY; DIAGNOSIS; DISEASE CONTROL; DISEASES; HYPERTHERMIA THERAPY; MAGNETIC PROPERTIES; MAGNETIC RESONANCE IMAGING; MAGNETISM; MEDICAL APPLICATIONS; METAL NANOPARTICLES; METALS; NANOPARTICLES; NANOSTRUCTURES; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY; TUMORS;

BIMETALLIC NANOPARTICLES; BIOLOGY AND MEDICINE; BIOMEDICAL APPLICATIONS; CORE-SHELL NANOPARTICLES; FE-BASED; HYPERTHERMIA; IRON METAL; MAGNETIC NANO-PARTICLES; NANOFLUIDS;

NANOMAGNETICS;

IRON; NANOPARTICLE; OXIDE;

BIOLOGY; CHEMISTRY; MEDICINE; RESEARCH; REVIEW; ULTRASTRUCTURE;

BIOLOGY; IRON; MEDICINE; NANOPARTICLES; OXIDES; RESEARCH;

EID: 84896343203     PISSN: 18722105     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872210507666131117183008     Document Type: Review

References (156)

1. He H, Dai H, Zi X. Apparatus and process for metal oxides and metal nanoparticles synthesis. US8133441, 2012.
2. Fujii T, Hashimoto H, Nakanishi M, Takada J. Magnetic ceramic and process for production thereof. US20120248368A1, 2012.
3. Bartling S, Margel S, Aviv H. Multimodal visible polymer embolization material. US20120184642A1, 2012.
4. Teughels S, Vaes P. Magnetic resonance imaging of single domain nanoparticles. US20130015857A1, 2013.
5. Teughels S, Vaes P. Magnetic resonance imaging of single domain nanoparticles. US8283926B2, 2012.
6. Bossmann SH, Troyer D, Basel MT, et al. MRI and optical assays for proteases. US20120157824A1, 2012.
7. Chen S, Hu S, Liu D, Kuo K. Drug delivery nanodevice, its preparation method and uses thereof. US20110014296 A1, 2011.
8. Bikram M. Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof. US8147803 B2, 2012.
9. Wolf GL, Lewis JM. Macrophage-Enhanced MRI (MEMRI) in a single imaging session. US20120003160 A1, 2012.
10. Malecki M, Malecki R. Multidomain biotags for cancer detection, diagnosis and therapy and methods and their use. US20120093733 A1, 2012.
11. Malecki M, Malecki R. Methods for in vivo cancer detection, diag nosis and therapy using multidomain and biotags. US20120087860 A1, 2012.
12. Duan DR, Nyborg A, Rudolph A, Wegrzyn R. Use of pyrene to carry peptides across the blood brain barrier. EP2268314 A2, 2011.
13. Rusu V, Borm P. Instruments coated with iron oxide nanoparticles for invasive medicine. US20120053572 A1, 2012.
14. Ziv I, Shirvan A. Perturbed membrane-binding compounds and methods of using the same. US7947253 B2, 2011.
15. Hummel H, Weiler VU. Targeting agents for molecular imaging. US20090246127A1, 2009.
16. Feldmann C, Braess H, Opitz J, Merikhi J. Contrast agent for medical imaging techniques and usage thereof. US20070258888A1, 2007.
17. Lee WD. NMR device for detection of analytes. US8310232, 2012.
18. Lee WD. NMR device for detection of analytes. US8310231, 2012.
19. Lee WD. NMR device for detection of analytes. US8102176, 2012.
20. Varma RS, Polshettiwar V. Magnetic nanoparticle-supported glu-tathione as a sustainable organocatalyst. US8324125, 2012.
21. Haik Y. Noninvasive thermometry monitoring system. US20120184872A1, 2012.
22. Wahajuddin, Arora S. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine 2012; 7: 3445-3471.
23. Na HB, Song IC, Hyeon T. Inorganic nanoparticles for MRI contrasts agents. Adv Mater 2009; 21:2133-2148.
24. Teja AS, Koh PY. Synthesis, properties, and applications of magnetic iron oxide nanoparticles. Cryst Growth Character Mater 2009; 55: 22-45.
25. Colombo M, Carregal-Romero S, Casula MF, et al. Biological applications of magnetic nanoparticles. Chem Soc Rev 2012; 41: 4306-4334.
26. Lu A, Salabas EL, Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed 2007; 46(8): 1222-1244.
27. Huber DL. Synthesis, properties, and applications of iron nanopar-ticles. Small 2005; 1(5): 482-501.
28. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparti-cles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108: 2064-2110.
29. Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparti-cles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 2012; 112 (11): 5818-5878
30. Thanh NTK. Magnetic Nanoparticles: From Fabrication to Clinical Applications: Theory to Therapy, Chemistry to Clinic, Bench to Bedside. CRC Press 2012.
31. Majewski P. In: Kumar CSSR, Ed. Nanomaterials for water treatment. Wiley 2006: pp. 211-233.
32. Ingvarsson ST, Trouilloud PL, Sun S, Koch RH, Abraham DW. Magnetic materials having superparamagnetic particles. US8324009, 2012.
33. Breton MP, Veregin RPN, Moffat KA, Kazmaier PM, Burns PA, Smith PF. Ferromagnetic nanoparticles with high magnetocrystal-line anisotropy for MICR ink applications. US8236192, 2012.
34. Veregin RPN, Moffat KA, Breton MP, Kazmaier PM, Burns PA, Smith PF. Ferromagnetic nanoparticles with high magnetocrystal-line anisotropy for MICR toner applications. US8137879, 2012.
35. Jun M. Magnetic material, and method for producing the same. JP2009062605A2, 2009.
36. Gabay A, Cui B, Marinescu M, Liu J, Hadjipanayis GC. Composite permanent magnets made from nanoflakes and powers. US20120019341A1, 2012.
37. Fuchs A, Gordaninejad F, Gecol H, Hu B, Kavlicoglu B, Sutrisno J. Nanostructured magnetorheological polymer fluids and gels. US8241517, 2012.
38. Shim I, Joung J, Lee K. Methods for surface modification of non-dispersible metal nanoparticles and modified metal nanoparticles for inkjet by the same method. US8173210, 2012.
39. Lin H, Lin W, Liou W, Chen C, Jian Z, Wu S. One dimension nano magnetic wires and manufacturing method thereof. US8152893, 2012.
40. Porter KA, Barnhardt EK. Synthesis and use of intermetallic iron palladium nanoparticle compositions. US8114807, 2012.
41. Ingvarsson ST, Trouilloud PL, Sun S, Koch RH, Abraham DW. Magnetic materials having superparamagnetic particles. US7880208, 2011.
42. Gubin SP. Magnetic nanoparticles. 2009, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
43. Gileadi E, Penner A. Method and device for electrochemical formation of therapeutic species in vivo. US8303643, 2012.
44. SArney MS, Atanasoska L, Feng JQ, et al. Self-buffering medical implants. US8267992, 2012.
45. Weber J. Bioerodible endoprosthesis. US8236046, 2012.
46. Porter KA, Barnhardt EK. Synthesis and use of intermetallic iron palladium nanoparticle compositions. US8114807, 2012.
47. Flanagan A. Bioabsorbable metal medical device and method of manufacture. US8089029, 2012.
48. Atanasoska L, Weber J, Warner RW. Bioerodible endoprostheses and methods of making the same. US8080055, 2011.
49. Lee C, Jeon SL, Chae MK, Cho J, Jang EJ. Iron oxide nanoparti-cles as MRI contrast agents and their preparing method, US20110165086A1, 2011.
50. 4 cored magnetic-quantum dot nanohyper thermia of cancer cells. US20110237862A1, 2011.
51. Stewart M, Susumu K, Farrell D, Mattoussi HM. Metal oxide-chelating ligands. US8222449, 2012.
52. Chaumonnot A, Coupe A, Sanchez C, Boissiere C, Grosso D. Inorganic material that has metal nanoparticles that are trapped in a mesostructured matrix. US8226740, 2012.
53. Perez JM, Santra S. Multimodal, multifunctional polymer coated nanoparticles. US8236284, 2012.
54. 3 nanoparticles prepared by transformation of a-FeOOH. Chinese Sci Bull 2011; 56: 2383-2388.
55. 3 Particles. Chem Mater 1996; 8(9): 2209-2211.
56. 3 phase transition temperature. Nanotechnology 2006; 17: 5851-5857.
57. 3 nanoparticles through a controlled shape transformation. J Phys Chem C 2013; 117(21): 11242-11250.
58. 4 (M=Fe, Co, Mn) nanoparticles. J Am Chem Soc 2004; 126: 273-279.
59. Long NV, Kitazaki M, Yoshida S, et al. Synthesis and structure of Fe-based metal and oxide nanoparticles by polyol method for potential applications in catalysis, biology, and medicine. The 6th International Workshop on Advanced Materials Science and Nanotechnology. Ha Long, Vietnam, October 30-November 2, 2012.
60. Long NV, Ohtaki M, Uchida M, et al. Synthesis and characterization of polyhedral Pt nanoparticles: Their catalytic property, surface attachment, self-aggregation and assembly. J Colloid Interf Sci 2011; 359: 339-350.
61. Gharibshahi E, Saion E. Influence of dose on particle size and optical properties of colloidal platinum nanoparticles. Int J Mol Sci 2012; 13: 14723-41.
62. Sun S, Zeng H. Size-Controlled Synthesis of Magnetite Nanoparticles. J Am Chem Soc 2002; 124: 8204-8205
63. Porcel E, Liehn S, Remita H, et al. Platinum nanoparticles: a promising material for future cancer therapy? Nanotechnology 2010; 21(8):85103.
64. Sun C, Lee JSH, Zhang M. Magnetic Nanoparticles in MR Imaging and drug delivery. Adv Drug Deliv Rev 2008; 60: 1252-1265.
65. Kim DK, Kan D, Veres T, et al. Monodispersed Fe-Pt nanoparticles for biomedical applications. J. Appl Phys 2005; 97: 10Q9181-10Q9183.
66. Jain KK. The Handbook of Nanomedicine. Humana Press, Springer Science+Business Media, LLC 2008.
67. Bullinger HJ. Technology Guide: Principles-Applications-Trends. Springer-Verlag Berlin Heidelberg 2009.
68. Soares PI, Ferreira IM, Igreja RA, Novo CM, Borges JP. Application of hyperthermia for cancer treatment: recent patents review. Recent Pat Anticancer Drug Discov 2012; 7: 64-73.
69. Zhou Z, Bao J, Chen X, et al. Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging. ACS Nano 2013; 7(4): 3287-3296.
70. Cao J. Methods and compositions for the diagnosis and treatment of cancer. WO2010011281A3, 2010.
71. Turner PF. Hyperthermia apparatus. US4798215, 1989.
72. Delannoy J, Bihan DL, Chen C, Levin R, Turner R. Apparatus for hyperthermia treatment of cancer. US5284144, 1994.
73. Haik Y, Chen C. Magnetic particle composition for therapeutic hyperthermia. US7842281, 2010.
74. Zhong C, Wang L, Luo J. Method of forming iron oxide core metal shell nanoparticles. US7829140, 2010.
75. Haj AJHE, Dobson JP. Generation of cartilage using magnetizable particles. US7625562, 2009.
76. Darton NJ, Hallmark B, Han X, Palit S, Slater NKH, Mackley MR. The in-flow capture of superparamagnetic nanoparticles for targeting therapeutics. Nanomedicine 2008; 4: 19-29.
77. Yang C, Rait A, Pirollo KF, Dagata JA, Farkas N, Chang EH. Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo. Nanomedicine 2008; 4: 318-329.
78. Weindel K, Riedling M, Geiger A. Magnetic glass particles, method for their preparation and uses thereof. US20050266462A1, 2005.
79. Hagmann M, Turner PF, Youd TL. Deep heating hyperthermia using phased arrays and patient positioning. US8306628, 2012.
80. Salour MM. Multiple sensing tip optical fiber thermometer. US8206030, 2012.
81. Salour MM. Imaging temperature sensing system. US8201997, 2012.
82. Buckley PR, Maitland DJ. Shape memory system with integrated actuation using embedded particles. US8187252, 2012.
83. Wilson TS, Maitland DJ. Shape memory polymer foams for endo-vascular therapies. US8133256, 2012.
84. Parel J, Manns F, Robinson DS, Milne P, Denham DB, Gonzalez-Cirre X. Intraoperative monitoring of temperature-induced tissue changes with a high-resolution digital X-ray system during ther-motherapy. US8099147, 2012.
85. Sahadevan V. Few seconds beam on time, breathing synchronized image guided all fields simultaneous radiation therapy combined with hyperthermia. US8139714, 2012.
86. Mon J, Fenn AJ. Drug delivery. US8224455, 2012.
87. Mon J, Smith D. Device and method for treatment of tissue adjacent a bodily conduit by thermocompression. US8221413, 2012.
88. Azure L. Ablation probe with deployable electrodes. US8109926, 2012.
89. Kulstad E, Caherty HP. Devices and methods for controlling patient temperature. US8231664, 2012.
90. Pedersen LG, Purkait B. External ultrasound lipoplasty. US8262591, 2012.
91. Anderson D, Cameransi BGJ, Conklin VM. Treatment using dan-trolene. US8110225, 2012.
92. Foo TK, Zhu Y. Method and apparatus for generating a localized heating. US8311641, 2012.
93. Podhajsky RJ, Coe JA. Specific absorption rate measurement and energy-delivery device characterization using thermal phantom and image analysis. US8188435, 2012.
94. Beaudin SA. Apparatus, system and methods for extracorporeal blood processing for selectively cooling the brain relative to the body during hyperthermic treatment or to induce hypothermia of the brain. US20120029408A1, 2012.
95. Brannan JD. Surface ablation antenna with dielectric loading. US8328801B2, 2012.
96. Brannan JD. Directive window ablation antenna with dielectric loading. US8328800, 2012.
97. Daraio C, Rizzo P. Method and apparatus for nondestructive evaluation and monitoring of materials and structures. US8327709, 2012.
98. Cornell RM, Schwertmann U. The Iron Oxides: Structure, properties, reactions, occourences and uses, 2003, John Wiley & Sons, Inc., Verlag GmbH & Co. KGaA, Weinheim.
99. Dravid VP, Sharma S, Tomita T, Viola KL, Klein WL. Magnetic nanostructures as theranostic agents. US20120308657A1, 2012.
100. Kiss Z. Use of one or more metal carriers to selectively kill mammalian cells. EP1901762A2, 2008.
101. Lodhia J, Mandarano G, Ferris NJ, Eu P, Cowell SF. Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI. Biomed Imaging Interv J 2010; 6(2): e12.
102. Mandarano G, Lodhia J, Eu P, Ferris NJ, Davidson R, Cowell SF. Development and use of iron oxide nanoparticles (Part 2): The application of iron oxide contrast agents in MRI. Biomed Imaging In-terv J 2010; 6(2): e13.
103. Alexander EJ, Andriacchi TP, Lang P, Steines D. Assessing the condition of a joint and devising treatment. USRE43282, 2012.
104. Ahrens ET, Srinivas M. Cellular labeling and quantification for nuclear magnetic resonance techniques. US8263043, 2012.
105. Ahrens ET. Cellular labeling for nuclear magnetic resonance techniques. US8147806, 2012.
106. Lang P, Steines D. Assessing the condition of a joint and devising treatment. US8306601, 2012.
107. Alexander EJ, Andriacchi TP, Lang P, Napel SA. Assessing the condition of a joint and preventing damage. US8265730, 2012.
108. Steines D, Zhuravlev A. Automated systems for manufacturing patient-specific orthopedic implants and instrumentation. US8234097, 2012.
109. Janjic J, Ahrens ET. Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques. US8227610, 2012.
110. Alexander EJ, Andriacchi TP, Lang P, Steines D. Assessing the condition of a joint and devising treatment. US8112142, 2012.
111. Hamilton CA, Hundley WG. Cardiac diagnostics using wall motion and perfusion cardiac MRI imaging and systems for cardiac diagnostics. US8290567, 2012.
112. Mostafavi H. Patient visual instruction techniques for synchronizing breathing with a medical procedure. US8200315, 2012.
113. Du J. Selective magnetic resonance imaging. US8148979, 2012.
114. Du J. Magnetic resonance imaging with high spatial and temporal resolution. US8120358, 2012.
115. Hundley WG, Hamilton CA, D'Agostino RB. Cardiac visualization systems for displaying 3-D images of cardiac voxel intensity distributions with optional physician interactive boundary tracing tools. US8103073, 2012.
116. Dale A, Gicquel S. Atlas and methods for segmentation and alignment of anatomical data. US8140144, 2012.
117. Ginggen A. System and method for controlling an implantable medical device subject to magnetic field or radio frequency exposure. US8090445, 2012.
118. Ahrens E. Contrast agents for magnetic resonance imaging and methods related thereto. US8084017, 2011.
119. Buracas G. Detecting spin perturbations using magnetic resonance imaging. US8248069, 2012.
120. Butson CR, McIntyre C. System and method to design structure for delivering electrical. US8209027, 2012.
121. Lee K. Chemical processing of nanoparticles. US7816297B2, 2010.
122. Ross BD, Rehemtulla A, Chenevert TL, et al. Systems and methods for tissue imaging. US8185186, 2012.
123. Dormer KJ, Po SS, Scherlag BJ, Pope CN. Magnetically-Targeted Treatment for cardiac disorders. US20120095442A1, 2012.
124. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005; 5(3): 161-171.
125. Pathak AP. Magnetic resonance susceptibility based perfusion imaging of tumors using iron oxide nanoparticles. Wiley Interdis-cip Rev Nanomed Nanobiotechnol 2009; 1: 84-97.
126. Cutler JI, Daniel WL, Giljohann DA, Mirkin CA, Zhang K, Zheng D. Templated nanoconjugates. US20120282186 A1, 2012.
127. Ryvolova M, Chomoucka J, Drbohlavova J, et al. Modern Micro and Nanoparticle-Based Imaging Techniques. Sensors 2012; 12: 14792-14820.
128. Chen TJ, Cheng TH, Hung YC, Lin KT, Liu GC, Wang YM. Targeted folic acid-PEG nanoparticles for noninvasive imaging of fo-late receptor by MRI. J Biomed Mater Res A 2008; 87(1): 165-175.
129. Invernici G, Cristini S, Alessandri G, et al. Nanotechnology advances in brain tumors: the state of the art. Recent Pat Anticancer Drug Discov 2011; 6(1): 58-69.
130. Ho D, Sun X, Sun S. Monodisperse Magnetic Nanoparticles for Theranostic Applications. Acc Chem Res 2011; 44: 875-882.
131. Freitas JRA. What is nanomedicine? Nanomedicine 2005; 1: 2-9.
132. Yih TC, Wei C. Nanomedicine in cancer treatment. Nanomed Nanotechnol Biol Med 2005; 1: 191-192.
133. 4@Au Nanoparticles. J Phys Chem B 2005; 109(46): 21593-21601.
134. Meeks ND, Smuleac V, Stevens C, Bhattacharyya D. Iron-based nanoparticles for toxic organic degradation: silica platform and green synthesis. Ind Eng Chem Res 2012; 51(28): 9581-9590.
135. Ma YH, Chen SY, Tu SJ, Yang HW, Liu HL. Manipulation of magnetic nanoparticle retention and hemodynamic consequences in microcirculation: assessment by laser speckle imaging. Int J Nanomedicine 2012; 7: 2817-2827.
136. Rudzka K, Delgado ÁV, Viota JL. Maghemite functionalization for antitumor drug vehiculization. Mol Pharmaceutics 2012; 9(7): 2017-2028.
137. Park JI, Jagadeesan D, Williams R, et al. Microbubbles loaded with nanoparticles: a route to multiple imaging modalities. ACS Nano 2010; 4 (11): 6579-6586.
138. Yu MK, Park J, Jon S. Magnetic nanoparticles and their applications in image-guided drug delivery. Drug Deliv Transl Res 2012; 2: 3-21.
139. Vigneshwaran N, Jain P. Chapter 6: Biomolecules-nanoparticles: interaction in nanoscale. M. Rai and N. Duran (eds.), metal nano-particles in microbiology, Springer-Verlag Berlin Heidelberg 2011.
140. Pitkethy MJ. Nanoparticles as building blocks. Mater Today 2003; 6:36-42.
141. Giouroudi I, Kosel J. Recent progress in biomedical applications of magnetic nanoparticles. Recent Pat Nanotechnol 2010; 4(2): 111-118.
142. Laurent S, Bridot JL, Elst LV, Muller RN. Magnetic iron oxide nanoparticles for biomedical applications. Future Med Chem 2010; 2(3): 427-449.
143. Shubayev VI, Pisanic II TR, Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 2009; 61(6): 467-477.
144. Herrera-Becerra R, Zorrilla C, Rius JL, Ascencio JA. Electron microscopy characterization of biosynthesized iron oxide nanopar-ticles. Appl Phys A 2008; 91: 241-246.
145. Petrov YI, Shafranovsky EA. Structure and magnetic properties of aerosol nanoparticles of fe and its alloys. Int J Inorg Chem 2012; 610305.
146. Lien HL, Zhang W. Nanoscale iron particles for complete reduction of chlorinated ethenes. Colloids Surf A 2001; 191(1-2): 97-105.
147. Lacroix LM, Ho D, Sun S. Magnetic nanoparticles as both imaging probes and therapeutic agents. Curr Top Med Chem. 2010; 10(12): 1184-1197.
148. CSSR. Biofunctionalization of Magnetic Nanoparticles Biofunctionalization of Nanomaterials. 2005, vol. 1, Wiley-VCH, Winheim, pp.72-98.
149. Naqvi S, Samim M, Abdin M, et al. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxida-tive stress. Int J Nanomedicine 2010; 5: 983-989.
150. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamag-netic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Adv Drug Delivery Rev 2011; 63: 24-46.
151. Castro AJR, Marques SPD, Soares JM, Filho JM, Saraiva GD, Oliveira AC. Nanosized aluminum derived oxides catalysts prepared with different methods for styrene production. Chem Eng J 2012; 209: 345-355
152. Laurent S, Dutz S, Häfeli UO, Mahmoudi M. Magnetic fluid hyper-thermia: Focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci 2011; 166(1-2): 8-23.
153. Araujo JCSD, Sousa CBA, Oliveira AC, Freire FNA, Ayala AP, Oliveira AC. Dehydrogenation of ethylbenzene with CO2 to produce styrene over Fe-containing ceramic composites. Appl Catal A 2010; 377(1-2): 55-63.
154. Jenkins JT, Halaney DL, Sokolov KV, et al. Excretion and toxicity of gold-iron nanoparticles. Nanomed Nanotechnol Biol Med 2013; 3: 356-365.
155. Nogueira IM, Sabadia GQ, Moreira AA, Filho JM, Oliveira AC. Investigation of the deactivation of iron nanocomposites by coking in the dehydrogenation of ethylbenzene. J Mol Catal A: Chem 2011; 351: 81-92.
156. Tang SCN, Lo IMC. Magnetic nanoparticles: Essential factors for sustainable environmental applications. Water Res 2013; 47: 2613-32.